Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: Results of GISSI-Prevenzione trial

Lipids

Volumn 36, Issue SUPPL., 2001, Pages

  Marchioli, Roberto ^a,b,f   Schweiger, Carlo ^c   Tavazzi, Luigi ^d   Valagussa, Franco ^e  

^a ANMCO RESEARCH CENTER   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c RHO HOSPITAL   (Italy)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e Ospedale di Monza   (Italy)

^f NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG THERAPY; HEALTH CARE; HEALTH RISKS; NUTRITION;

CORONARY HEART DISEASE PATIENTS;

FATTY ACIDS;

ALPHA TOCOPHEROL; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

SIGANUS;

EID: 0035700932     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-001-0694-8     Document Type: Conference Paper

References (67)

1. The composition of food consumed by Greenland Eskimos
2. Epidemiologic studies in the Upernavik district, Greenland, incidence of some chronic disease (1950-1974)
3. Omega-3 fatty acids in health and disease and growth and development
4. ω-3 fatty acids in the prevention-management of cardiovascular disease
5. Dietary intake of marine n-3 fatty acids, fish intake and the risk of coronary disease among men
6. Fish consumption and risk of sudden cardiac death
7. The inverse relationship between fish consumption and 20-year mortality from coronary heart disease
8. Fish consumption and the 30-year risk of fatal myocardial infarction
9. Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial
10. Fish intake may limit the increase in risk of coronary heart disease morbidity and mortality among heavy smokers: The Honolulu Heart Program
11. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: Final report of the lyon diet heart study
12. Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: Results of one year follow-up
13. Randomized, double-blind placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: The Indian experiment of infarct survival-4
14. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial
15. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART)
16. n-3 fatty acids and serum lipoproteins: Human studies
17. n-3 fatty acids and serum lipoproteins: Animal studies
18. Dietary Lipid Modulation of Ventricular Fibrillation Threshold in the Marmoset Monkey
19. Relative effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on cardiac arrhythmias in rats
20. Antiarrhythmic effects of polyunsaturated fatty acids: Recent studies
21. Prevention of ischemia-induced ventricular arrhythmias by dietary pure n-3 polyunsaturated fatty acids in dogs
22. Effects of dietary fish oil on ventricular premature complexes
23. Effect of fish oil on heart rate variability in survivors of myocardial infarction: A double-blind randomised controlled trial
24. Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction
25. Dietary intake and cell membrane levels of long-chain ω-3 polyunsaturated fatty acids and the risk of primary cardiac arrest
26. Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes
27. Prevention and termination of the β-adrenergic agonist-induced arrhythmias by free polyunsaturated fatty acids in neonatal rat cardiac myocytes
28. Free long-chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes
29. + channels of neonatal rat ventricular myocytes
30. 2+ currents by polyunsaturated fatty acids in adult and neonatal rat cardiac myocytes
31. + channel
32. Il quadro di riferimento biochimico, farmacologico, epidemiologico del Gissi-prevenzione
33. Il protocollo dello studio Gissi-prevenzione: Studio di intervento preventivo sulle componenti aterosclerotica e trombotica del rischio post-infarto
34. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin e after myocardial infarction: Results of the GISSI-Prevenzione trial
35. Effect of long-term fish oil supplementation on vitamin E status and lipid peroxidation in women
36. Antioxidant vitamins and prevention of cardiovascular disease: Laboratory epidemiological, and clinical trial data
37. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity
38. Antioxidants and atherosclerosis: A current assessment
39. Antioxidants in the prevention of human atherosclerosis
40. Antioxidants and atherosclerotic heart disease
41. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers
42. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
43. Mortality in the CHAOS trial
44. Mortality in the CHAOS trial
45. Do vitamin E and fish oil protect against ischaemic heart disease?
46. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infraction
47. What accounts for the association of vegetables and fruit with lower incidence of cancers and coronary heart disease?
48. Vitamin E consumption and the risk of coronary heart disease in men
49. Vitamin E consumption and the risk of coronary disease in women
50. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women
51. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women
52. Effect of in-vivo supplementation with low-dose vitamin E on susceptibility of low-density lipoprotein and high-density lipoprotein to oxidative modification
53. Vitamin E and human health: Rationale for determining recommended intake levels
54. A randomized, single-blind, placebo-controlled trial of the effects of 200 Mg α-tocopherol on the oxidation resistance of atherogenic lipoproteins
55. Vitamin E supplementation in elderly lowers the oxidation rate of linoleic acid in LDL
56. The 2 × 2 factorial design: Its applications to a randomized trial of aspirin and carotene in U.S. Physicians
57. Factorial designs for randomized clinical trials
58. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
59. Intake of fatty acids and risk of coronary heart disease in a cohort of finnish men: The alpha-tocopherol, beta-carotene cancer prevention study
60. Omega-3 fatty acids in adipose tissue and risk of myocardial infarction: The EURAMIc Study
61. n-3 fatty acids in adipose tissue and coronary heart disease are inversely related
62. GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction
63. GISSI-3: Effects of Lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction
64. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction
65. AHA Dietary Guidelines Revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association
66. The results of the GISSI-Prevenzione trial in the general framework of secondary prevention